Other microRNAs, such as miR-885-3p, have been shown to target the AKT pathway beneficially, for instance, improving glucocorticoid sensitivity in Graves’ ophthalmopathy by inhibiting AKT/NFKB signaling47. This evidence concerns the gene AKT1 and Graves ophthalmopathy.